Mild redness, swelling, or tenderness that resolves within a few hours is normal and does not indicate an allergic response
Food and Drug Administration (FDA) officially approved Zepbound (tirzepatide) injection, under the brand name Mounjaro for chronic weight management in 2023
The blue nevus is usually asymptomatic, with color variations of gray, brown, slate-blue, and blue-black in color (Tyndall effect) and rarely measures over 6 mm (see Figure 2)
People with a personal or family history of medullary thyroid carcinoma or MEN 2, pregnant or breastfeeding women, people with a history of pancreatitis, severe kidney disease, type 1 diabetes, children and adolescents, people with gastroparesis or severe GI disease, and people with certain unstable cardiovascular conditions
For obesity treatment, dose escalation protocols starting at lower doses (e.g., 2 mg) and gradually increasing to maintenance doses (e.g., 4 mg, 8 mg, or 12 mg) have been studied Link below for more detailed information: Product Overview: Retatru/Cagrilintide is a dual-compound research peptide combining Retatru, a novel multi-agonist peptide with activity across GLP-1, GIP, and glucagon pathways, and Cagrilintide, an amylin analog
GI discomfort: Nausea or stomach upset has been occasionally noted in anecdotal reports